# Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer

> **NCT00004931** · PHASE3 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 2472 (estimated)

## Conditions studied

- Stage II Colon Cancer
- Stage III Colon Cancer

## Interventions

- **DRUG:** leucovorin calcium
- **DRUG:** fluorouracil
- **DRUG:** oxaliplatin
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00004931
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-02
- **Primary completion:** 2005-09
- **Final completion:** —
- **Target enrollment:** 2472 (ESTIMATED)
- **Last updated:** 2013-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004931, "Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00004931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*